Phenolic Profiling of Laurus nobilis by LC–ESI–MS/MS: In Vitro Bioactivities and In Silico Enzyme Docking
Özet
This study evaluated the branch, leaf, and fruit extracts of Laurus nobilis collected from Artvin in terms of phenolic composition, antioxidant, antimicrobial, and antidiabetic activities and additionally investigated the binding of selected phenolics to α-amylase/α-glucosidase targets through molecular docking. Using LC–ESI–MS/MS analysis, 31 phenolic compounds were quantitatively identified, with epicatechin, luteolin-7-O-glucoside, and rutin predominating particularly in the branches and leaves. Antioxidant capacity was higher in branches and leaves (total phenolic content [TPC]/FRAP/DPPH IC50: branches and leaves, respectively, 95.27–60.84 mg gallic acid equivalent [GAE]/g, 206.16–162.05 mg Trolox equivalent [TE]/g, and 46.95–113.49 µg/mL). Antimicrobial activity was observed within a minimum inhibitory concentration (MIC) range of 1.25–10 mg/mL; leaves exhibited the strongest effect against Bacillus cereus (1.25 mg/mL), whereas fruits were most effective against Candida albicans (1.25 mg/mL). In antidiabetic evaluation, fruits yielded the lowest IC50 values against α-amylase and α-glucosidase (4.31 and 8.97 mg/mL, respectively), suggesting a “composition-over-quantity” effect despite low total phenolic content. Docking results supported high binding affinities of rutin (α-glucosidase −9.3 kcal/mol; α-amylase −8.1 kcal/mol) and luteolin (−8.6 kcal/mol for both enzymes). Overall, although branches and leaves exhibited strong antioxidant profiles, fruits showed more pronounced inhibitory effects on digestive enzymes; therefore, fractionation studies and in vivo/kinetic validations are recommended.
Anahtar Kelimeler
- Scopus
- 3
- WoS
- 3
- OpenAlex
- 6
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Bak, Funda Erşen | |
| dc.contributor.author | Canbolat Gültekin, Deniz | |
| dc.contributor.author | Akmeşe, Osman | |
| dc.contributor.author | Atalay, Abdurrahman | |
| dc.contributor.author | Turan, İbrahim | |
| dc.contributor.author | Gültekin, Ergün | |
| dc.contributor.author | Demir, Selim | |
| dc.contributor.author | Aliyazicioglu, Yüksel | |
| dc.date.accessioned | 2026-10-22T10:21:37.952917668Z | |
| dc.date.available | 2026-10-22T10:21:37.952917668Z | |
| dc.date.issued | 2026 | |
| dc.description.abstract | This study evaluated the branch, leaf, and fruit extracts of Laurus nobilis collected from Artvin in terms of phenolic composition, antioxidant, antimicrobial, and antidiabetic activities and additionally investigated the binding of selected phenolics to α-amylase/α-glucosidase targets through molecular docking. Using LC–ESI–MS/MS analysis, 31 phenolic compounds were quantitatively identified, with epicatechin, luteolin-7-O-glucoside, and rutin predominating particularly in the branches and leaves. Antioxidant capacity was higher in branches and leaves (total phenolic content [TPC]/FRAP/DPPH IC50: branches and leaves, respectively, 95.27–60.84 mg gallic acid equivalent [GAE]/g, 206.16–162.05 mg Trolox equivalent [TE]/g, and 46.95–113.49 µg/mL). Antimicrobial activity was observed within a minimum inhibitory concentration (MIC) range of 1.25–10 mg/mL; leaves exhibited the strongest effect against Bacillus cereus (1.25 mg/mL), whereas fruits were most effective against Candida albicans (1.25 mg/mL). In antidiabetic evaluation, fruits yielded the lowest IC50 values against α-amylase and α-glucosidase (4.31 and 8.97 mg/mL, respectively), suggesting a “composition-over-quantity” effect despite low total phenolic content. Docking results supported high binding affinities of rutin (α-glucosidase −9.3 kcal/mol; α-amylase −8.1 kcal/mol) and luteolin (−8.6 kcal/mol for both enzymes). Overall, although branches and leaves exhibited strong antioxidant profiles, fruits showed more pronounced inhibitory effects on digestive enzymes; therefore, fractionation studies and in vivo/kinetic validations are recommended. | |
| dc.description.sponsorship | Artvin Çoruh Üniversitesi, ACU | |
| dc.description.sponsorship | Science-Technology Research and Application Center, Türkiye | |
| dc.identifier.articlenumber | e03616 | |
| dc.identifier.doi | 10.1002/cbdv.202503616 | |
| dc.identifier.eissn | 1612-1880 | |
| dc.identifier.issn | 1612-1872 | |
| dc.identifier.issue | 2 | |
| dc.identifier.pmid | 41631811 | |
| dc.identifier.scopus | 2-s2.0-105029306066 | |
| dc.identifier.startpage | e03616 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/gumushane/13669 | |
| dc.identifier.volume | 23 | |
| dc.identifier.wos | WOS:001707425200049 | |
| dc.language.iso | en | |
| dc.publisher | John Wiley and Sons Inc | |
| dc.relation.ispartof | Chemistry and Biodiversity | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | antioxidant activity | |
| dc.subject | Laurus nobilis | |
| dc.subject | LC–ESI–MS/MS | |
| dc.subject | phenolic compounds | |
| dc.subject | α-amylase/α-glucosidase inhibition | |
| dc.subject.classification | Biochemistry & Molecular Biology | |
| dc.subject.classification | Chemistry, Multidisciplinary | |
| dc.subject.classification | Chemistry | |
| dc.subject.other | alpha-Amylases | |
| dc.subject.other | alpha-Glucosidases | |
| dc.subject.other | Anti-Bacterial Agents | |
| dc.subject.other | Antioxidants | |
| dc.subject.other | Bacillus cereus | |
| dc.subject.other | Candida albicans | |
| dc.subject.other | Chromatography, Liquid | |
| dc.subject.other | Dose-Response Relationship, Drug | |
| dc.subject.other | Fruit | |
| dc.subject.other | Glycoside Hydrolase Inhibitors | |
| dc.subject.other | Hypoglycemic Agents | |
| dc.subject.other | Laurus | |
| dc.subject.other | Microbial Sensitivity Tests | |
| dc.subject.other | Molecular Docking Simulation | |
| dc.subject.other | Molecular Structure | |
| dc.subject.other | Phenols | |
| dc.subject.other | Plant Extracts | |
| dc.subject.other | Plant Leaves | |
| dc.subject.other | Spectrometry, Mass, Electrospray Ionization | |
| dc.subject.other | Tandem Mass Spectrometry | |
| dc.subject.other | 4 hydroxybenzoic acid | |
| dc.subject.other | acarbose | |
| dc.subject.other | alpha glucosidase | |
| dc.subject.other | amylase | |
| dc.subject.other | antidiabetic agent | |
| dc.subject.other | antiinfective agent | |
| dc.subject.other | antioxidant | |
| dc.subject.other | apigenin | |
| dc.subject.other | caffeic acid | |
| dc.subject.other | catechin | |
| dc.subject.other | chlorogenic acid | |
| dc.subject.other | chrysin | |
| dc.subject.other | ellagic acid | |
| dc.subject.other | epicatechin | |
| dc.subject.other | ferulic acid | |
| dc.subject.other | flavone | |
| dc.subject.other | galangin | |
| dc.subject.other | gallic acid | |
| dc.subject.other | gentisic acid | |
| dc.subject.other | hesperidin | |
| dc.subject.other | Laurus nobilis extract | |
| dc.subject.other | luteolin | |
| dc.subject.other | luteolin 7 glucoside | |
| dc.subject.other | luteolin 7 glycoside | |
| dc.subject.other | naringenin | |
| dc.subject.other | oleuropein | |
| dc.subject.other | para coumaric acid | |
| dc.subject.other | phenol derivative | |
| dc.subject.other | pinocembrine | |
| dc.subject.other | plant extract | |
| dc.subject.other | protocatechualdehyde | |
| dc.subject.other | protocatechuic acid | |
| dc.subject.other | quercetin | |
| dc.subject.other | resveratrol | |
| dc.subject.other | rosmarinic acid | |
| dc.subject.other | rutoside | |
| dc.subject.other | salicylic acid | |
| dc.subject.other | sesamol | |
| dc.subject.other | syringic acid | |
| dc.subject.other | taxifolin | |
| dc.subject.other | tetracycline | |
| dc.subject.other | trolox C | |
| dc.subject.other | unclassified drug | |
| dc.subject.other | vanillin | |
| dc.subject.other | glycosidase inhibitor | |
| dc.subject.other | antidiabetic activity | |
| dc.subject.other | antimicrobial activity | |
| dc.subject.other | antioxidant activity | |
| dc.subject.other | Article | |
| dc.subject.other | binding affinity | |
| dc.subject.other | chemical composition | |
| dc.subject.other | computer model | |
| dc.subject.other | DPPH radical scavenging assay | |
| dc.subject.other | drug protein binding | |
| dc.subject.other | electrospray mass spectrometry | |
| dc.subject.other | Enterococcus faecalis | |
| dc.subject.other | Escherichia | |
| dc.subject.other | ferric reducing antioxidant power assay | |
| dc.subject.other | fractionation | |
| dc.subject.other | IC50 | |
| dc.subject.other | in vitro study | |
| dc.subject.other | Klebsiella pneumoniae | |
| dc.subject.other | Laurus nobilis | |
| dc.subject.other | liquid chromatography-mass spectrometry | |
| dc.subject.other | minimum inhibitory concentration | |
| dc.subject.other | molecular docking | |
| dc.subject.other | nonhuman | |
| dc.subject.other | plant leaf | |
| dc.subject.other | plant stem | |
| dc.subject.other | quantitative analysis | |
| dc.subject.other | chemical structure | |
| dc.subject.other | chemistry | |
| dc.subject.other | dose response | |
| dc.subject.other | drug effect | |
| dc.subject.other | isolation and purification | |
| dc.subject.other | liquid chromatography | |
| dc.subject.other | metabolism | |
| dc.subject.other | microbial sensitivity test | |
| dc.title | Phenolic Profiling of Laurus nobilis by LC–ESI–MS/MS: In Vitro Bioactivities and In Silico Enzyme Docking | |
| dc.type | Article | |
| rdl.citation.openalex | 6 | |
| rdl.citation.scopus | 3 | |
| rdl.citation.wos | 3 | |
| rdl.department | Department of Biotechnology, Graduate School of Natural and Applied Sciences, Gumushane University, Gumushane, Türkiye | |
| rdl.oa.status | closed | |
| rdl.scopus.quartile | Q2 | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |
